Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Deblina SarkarPharmacology and Toxicology, Department of Biological Sciences and Pathobiology, University of Veterinary Medicine, 1210 Vienna, Austria.
Azra AletaPharmacology and Toxicology, Department of Biological Sciences and Pathobiology, University of Veterinary Medicine, 1210 Vienna, Austria.
Moris AhmetaševićPharmacology and Toxicology, Department of Biological Sciences and Pathobiology, University of Veterinary Medicine, 1210 Vienna, Austria.
Mira TosinPharmacology and Toxicology, Department of Biological Sciences and Pathobiology, University of Veterinary Medicine, 1210 Vienna, Austria.
Laura MachinPharmacology and Toxicology, Department of Biological Sciences and Pathobiology, University of Veterinary Medicine, 1210 Vienna, Austria.ORCID 0000-0002-0708-6789
Elisabeth SchrödlPharmacology and Toxicology, Department of Biological Sciences and Pathobiology, University of Veterinary Medicine, 1210 Vienna, Austria.
Markus BacherInstitute of Chemistry of Renewable Resources, Department of Natural Sciences and Sustainable Resources, UFT Research Center, BOKU University, 3430 Tulln, Austria.ORCID 0000-0002-4307-4849
Thomas RosenauInstitute of Chemistry of Renewable Resources, Department of Natural Sciences and Sustainable Resources, UFT Research Center, BOKU University, 3430 Tulln, Austria.ORCID 0000-0002-6636-9260
Lianet MonzoteParasitology Department, Institute of Tropical Medicine "Pedro Kouri", Havana 17100, Cuba.ORCID 0000-0002-1958-809X
Katrin StaniekPharmacology and Toxicology, Department of Biological Sciences and Pathobiology, University of Veterinary Medicine, 1210 Vienna, Austria.
Mitali ChatterjeeDepartment of Pharmacology, Institute of Postgraduate Medical Education and Research, Kolkata 700 020, India.
Lars GillePharmacology and Toxicology, Department of Biological Sciences and Pathobiology, University of Veterinary Medicine, 1210 Vienna, Austria.ORCID 0000-0003-1223-0201
Funding
OEAD (Austria's Agency for Education and Internationalisation) Ernst-Mach scholarships to Deblina Sarkar (2023) and Laura Machin (2021)
6 · The paper itself
Abstract
Leishmaniasis is a global health issue, especially in tropical and subtropical areas, with treatment challenges due to the development of resistance to current drugs. This has prompted the search for new antileishmanial compounds. Endoperoxides, due to parasites' reliance on external iron and susceptibility to oxidative stress, are promising antileishmanial compounds. This study evaluated two sterol endoperoxides-ergosterol endoperoxide (ErgoEP) and dehydrocholesterol endoperoxide (DHCholEP)-for their antileishmanial activity and mechanism in vitro. Cell viability assays with
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Sterol Endoperoxides and Their Antileishmanial Effects: Influence on Viability, Oxygen Metabolism and Sterol Synthesis. · full record | OpenQuestion